IRCT20220516054875N1尚未招募1 期
Exploring the pharmacist's intervention for precluding the factors effecting medication adherence in Chronic Obstructive Pulmonary Diseases (COPD) following GOLD (Global Initiative for Chronic Obstructive Lungs diseases) guidelines in Pakistan
Quaid-i-Azam University , Islamabad0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit(—)
- 性别
- All
入选标准
- •Patients only attend the outpatient COPD wards, confirmed diagnosis of COPD by the hospital consultant for at least 1 year
- •Newly diagnosed patients with a forced expiratory volume in 1 s (FEV1) of 30–80% of the predicted normal value
- •Patients that hospital consultant agree that the patient is suitable for entering the trial
排除标准
- •Moderate to severe learning difficulties
- •Mobility problems, confusion, disorientation or terminal illness
- •Congestive heart failure or if they are attending a pulmonary rehabilitation programs consulting a pulmonary nurse or clinical pharmacist in the last 6 months
研究者
相似试验
已完成
不适用
A pharmacist-led medicines review intervention in community-dwelling Maori older adults– a feasibility study.ACTRN12619001070123School of Pharmacy, University of Auckland17
已完成
不适用
Development of intervention tool and its effect on health care of patients with dyslipidemia by community pharmacistsDyslipidemiaJPRN-UMIN000044945Showa University40
尚未招募
不适用
A combined, tailored pharmacist intervention with dose optimization of phosphate binding drugs to improve phosphate control in patients on dialysis.NL-OMON24286Franciscus Gasthuis and Vlietland45
已完成
不适用
Influence investigation by the pharmacist follow after the medicatioDiabetesJPRN-UMIN000042922others Chiba Pharmaceutical Association37
已完成
不适用
Evaluation of Pharmacist Intervention for improving Adherence of Immunosuppressive Regimen in Kidney Transplant RecipientsKidney Transplant.Kidney transplant statusZ94.0IRCT20150706023084N9Islamic Azad University, Pharmaceutical Sciences Branch50
